Evidence map›Paper›PMID 39800463›Full record

ArticleThe journal of prevention of Alzheimer's disease2025

Plasma amyloid-β precursor protein

Moeko Noguchi-Shinohara, Yasuhiro Sakashita, Hiroto Nakano, Daiki Muramatsu, Sadao Hikishima, Junji Komatsu, Hidetomo Murakami, Yukiko Mori, Kenjiro Ono

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of prevention of Alzheimer's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Moeko Noguchi-ShinoharaDepartment of Neurology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Yasuhiro SakashitaDepartment of Neurology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Hiroto NakanoDepartment of Neurology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Daiki MuramatsuDepartment of Neurology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Sadao HikishimaDepartment of Neurology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Junji KomatsuDepartment of Neurology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Hidetomo MurakamiDepartment of Neurology, School of Medicine, Showa University, Tokyo, Japan.
Yukiko MoriDepartment of Neurology, School of Medicine, Showa University, Tokyo, Japan.
Kenjiro OnoDepartment of Neurology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan. Electronic address: onoken@med.kanazawa-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasma amyloid-β (Aβ) markers are significant predictors of Aβ pathology. However, their prognostic value for cognition in patients with Alzheimer's disease (AD) is unknown. We compared plasma amyloid-β precursor protein (APP)

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorCognitionCognitive DysfunctionPeptide FragmentsAgedAged, 80 and overBiomarkersFemaleHumansMaleMental Status and Dementia TestsMiddle AgedAmyloid beta-Peptidesamyloid beta-protein (1-42)Amyloid beta-Protein PrecursorBiomarkersPeptide FragmentsAlzheimer's diseaseAmyloid-β precursor proteinCognitionPlasma biomarkers

Identifiers

PMID39800463
PMCPMC12184047

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.